Rapid approval of drugs eyed

The Korea Food and Drug Administration said Thursday that it will revise the screening procedures for new rules as part of its efforts to provide better support for the domestic drug makers to develop specific drugs, such rare drug, children drugs and anti-cancers.

The KFDA also said it will promote the fast-track programs that are designed to facilitate the development and expedite the revi...